BG26536A4 - - Google Patents

Info

Publication number
BG26536A4
BG26536A4 BG7532817A BG3281775A BG26536A4 BG 26536 A4 BG26536 A4 BG 26536A4 BG 7532817 A BG7532817 A BG 7532817A BG 3281775 A BG3281775 A BG 3281775A BG 26536 A4 BG26536 A4 BG 26536A4
Authority
BG
Bulgaria
Application number
BG7532817A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10402412&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG26536(A4) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of BG26536A4 publication Critical patent/BG26536A4/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
    • C07D473/32—Nitrogen atom
    • C07D473/34—Nitrogen atom attached in position 6, e.g. adenine
BG7532817A 1974-09-02 1975-09-02 BG26536A4 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB38278/74A GB1523865A (en) 1974-09-02 1974-09-02 Purine compunds and salts thereof

Publications (1)

Publication Number Publication Date
BG26536A4 true BG26536A4 (fr) 1979-04-12

Family

ID=10402412

Family Applications (4)

Application Number Title Priority Date Filing Date
BG7500032819A BG24815A3 (en) 1974-09-02 1975-09-02 Method of obtaining substituted purines
BG7530910A BG26389A3 (fr) 1974-09-02 1975-09-02
BG7532817A BG26536A4 (fr) 1974-09-02 1975-09-02
BG7500032818A BG25094A3 (en) 1974-09-02 1975-09-02 A method of obtaining substituted purines

Family Applications Before (2)

Application Number Title Priority Date Filing Date
BG7500032819A BG24815A3 (en) 1974-09-02 1975-09-02 Method of obtaining substituted purines
BG7530910A BG26389A3 (fr) 1974-09-02 1975-09-02

Family Applications After (1)

Application Number Title Priority Date Filing Date
BG7500032818A BG25094A3 (en) 1974-09-02 1975-09-02 A method of obtaining substituted purines

Country Status (35)

Country Link
US (3) US4294831A (fr)
JP (1) JPS5154589A (fr)
AR (4) AR220299A1 (fr)
AT (1) AT354462B (fr)
AU (1) AU503160B2 (fr)
BE (1) BE833006A (fr)
BG (4) BG24815A3 (fr)
CA (1) CA1062257A (fr)
CH (7) CH626363A5 (fr)
CS (2) CS203092B2 (fr)
CY (1) CY1033A (fr)
DD (1) DD122092A5 (fr)
DE (1) DE2539963A1 (fr)
DK (1) DK146595C (fr)
ES (3) ES440631A1 (fr)
FI (1) FI60709C (fr)
FR (1) FR2282892A1 (fr)
GB (1) GB1523865A (fr)
HK (1) HK84379A (fr)
HU (1) HU176730B (fr)
IE (1) IE42282B1 (fr)
IL (1) IL48035A (fr)
KE (1) KE3002A (fr)
LU (1) LU73304A1 (fr)
MC (1) MC1068A1 (fr)
MY (1) MY8200191A (fr)
NL (1) NL175061C (fr)
NO (1) NO144216C (fr)
NZ (1) NZ178556A (fr)
RO (4) RO74276A (fr)
SE (1) SE428562C (fr)
SU (7) SU904523A3 (fr)
YU (4) YU39947B (fr)
ZA (1) ZA755574B (fr)
ZM (1) ZM12875A1 (fr)

Families Citing this family (114)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4146715A (en) 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines
US4060616A (en) * 1976-03-01 1977-11-29 Burroughs Wellcome Co. Purine derivatives with repeating unit
AU521577B2 (en) * 1977-02-24 1982-04-22 Wellcome Foundation Limited, The 9-hydroxyethoxymethyl guanine phosphates
US4287188A (en) 1977-02-24 1981-09-01 Burroughs Wellcome Co. Purine derivatives
KR830005852A (ko) * 1980-07-18 1983-09-14 미첼 페터 잭슨 피부와 점막의 비루스 감염치료에 적합한 국소치료제의 제조방법
US5157120A (en) * 1980-09-16 1992-10-20 Syntex (U.S.A.) Inc. Guanine derivatives
US4347360A (en) * 1980-09-16 1982-08-31 Ens Bio Logicals Inc. Ring open nucleoside analogues
AU547311B2 (en) * 1980-10-15 1985-10-17 Wellcome Foundation Limited, The Treating viral infections in fish
US4423050A (en) * 1981-05-21 1983-12-27 Syntex (U.S.A.) Inc. 9-(1,3-Dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4355032B2 (en) * 1981-05-21 1990-10-30 9-(1,3-dihydroxy-2-propoxymethyl)guanine as antiviral agent
US4603219A (en) * 1981-05-21 1986-07-29 Syntex (U.S.A.) Inc. 1,3-dibenzyloxy-2-acetoxymethoxypropane, intermediate for 9-(1,3-dihydroxy-2-propoxymethyl)guanine
DK154561C (da) * 1981-08-11 1989-04-24 Wellcome Found Analogifremgangsmaade til fremstilling af antivirale 9-substituerede 2-aminopurinderivater eller fysiologisk acceptable salte eller estere deraf
AU564576B2 (en) * 1981-09-24 1987-08-20 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Purine derivatives
US5250535A (en) * 1982-02-01 1993-10-05 Syntex Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
WO1983002723A1 (fr) * 1982-02-12 1983-08-18 Smith, Kendall, O. Compositions anti-virales
SE8203855D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine i
SE8203856D0 (sv) * 1982-06-21 1982-06-21 Astra Laekemedel Ab Novel derivatives of guanine ii
NL8202626A (nl) * 1982-06-29 1984-01-16 Stichting Rega V Z W Derivaten van 9-(2-hydroxyethoxymethyl)guanine.
US4649140A (en) * 1982-10-14 1987-03-10 Burroughs Wellcome Co. Purine derivatives
ZW22283A1 (en) * 1982-10-14 1985-05-22 Wellcome Found Antiviral compounds
US4745119A (en) * 1982-10-14 1988-05-17 Burroughs Wellcome Co. Method for using purine derivatives
US5059604A (en) * 1982-10-14 1991-10-22 Burroughs Wellcome Co. 2-amino purine derivatives
US4609662A (en) * 1982-10-14 1986-09-02 Burroughs Wellcome Co. Method for using purine derivatives
US4612314A (en) * 1982-12-22 1986-09-16 Syntex (U.S.A.) Inc. Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
US4461757A (en) * 1983-02-23 1984-07-24 Ens Bio Logicals Inc. Dimethylaminomethylenated anti-herpes compounds
ES520140A0 (es) * 1983-02-25 1984-04-01 Ind Farma Especial Un procedimiento para la preparacion de acicloguanosina.
US5047533A (en) * 1983-05-24 1991-09-10 Sri International Acyclic purine phosphonate nucleotide analogs
US4557934A (en) 1983-06-21 1985-12-10 The Procter & Gamble Company Penetrating topical pharmaceutical compositions containing 1-dodecyl-azacycloheptan-2-one
JPS6023380A (ja) * 1983-06-24 1985-02-05 メルク・エンド・カムパニー・インコーポレーテッド 抗ウイルス剤
US4880820A (en) * 1983-06-24 1989-11-14 Merck & Co., Inc. Guanine derivatives
US5684153A (en) 1984-08-16 1997-11-04 Beecham Group Plc Process for the preparation of purine derivatives
US4897479A (en) * 1983-09-30 1990-01-30 Merck & Co., Inc. Arylsulfonyloxy purine intermediates
JPS6094992A (ja) * 1983-10-28 1985-05-28 Sankyo Co Ltd グリゼオ−ル酸誘導体
US4806642A (en) * 1984-10-05 1989-02-21 Warner-Lambert Company Purine derivatives
ZA848080B (en) * 1983-10-31 1985-06-26 Warner Lambert Co Purine derivatives
IE842642L (en) * 1983-10-31 1985-04-30 Harvard College Purine Derivatives
US4918219A (en) * 1983-10-31 1990-04-17 Warner-Lambert Company Glycerine derivatives
US4579849A (en) * 1984-04-06 1986-04-01 Merck & Co., Inc. N-alkylguanine acyclonucleosides as antiviral agents
US4617304A (en) * 1984-04-10 1986-10-14 Merck & Co., Inc. Purine derivatives
DK163985A (da) * 1984-04-13 1985-10-14 Wellcome Found Antivirale purinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
US4636507A (en) * 1984-04-30 1987-01-13 Hoechst-Roussel Pharmaceuticals Inc. Host defense mechanism enhancement
EP0167385B1 (fr) 1984-07-03 1992-03-18 The Wellcome Foundation Limited Composés antiviraux, traitement et formulations
EP0190123A1 (fr) * 1984-07-20 1986-08-13 GAUNTT, Charles, O. Compose immunoregulateur et anti-viral
SE8406538D0 (sv) * 1984-12-21 1984-12-21 Astra Laekemedel Ab Novel derivatives of purine
US4724232A (en) * 1985-03-16 1988-02-09 Burroughs Wellcome Co. Treatment of human viral infections
US5683990A (en) * 1985-03-16 1997-11-04 Glaxo Wellcome Inc. Treatment of human viral infections
CS263951B1 (en) * 1985-04-25 1989-05-12 Antonin Holy 9-(phosponylmethoxyalkyl)adenines and method of their preparation
CS263952B1 (en) * 1985-04-25 1989-05-12 Holy Antonin Remedy with antiviral effect
EP0203736B1 (fr) 1985-05-02 1989-11-23 The Wellcome Foundation Limited Composés antiviraux
IL78643A0 (en) * 1985-05-02 1986-08-31 Wellcome Found Purine derivatives,their preparation and pharmaceutical compositions containing them
DE3529497A1 (de) * 1985-08-17 1987-02-26 Boehringer Mannheim Gmbh N(pfeil hoch)6(pfeil hoch)-disubstituierte purinderivate, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
DE3627024A1 (de) * 1985-09-24 1987-04-02 Hoechst Ag In 6- und 9-stellung substituierte 2-aminopurine, ihre verwendung, diese purine enthaltende arzneimittel und verfahren zur herstellung der purine
IT1207507B (it) * 1985-10-21 1989-05-25 Baldacci Lab Spa Coniugato della 9-(2-idrossietossimetil)guanina con albumina umana lattosaminata, procedimento per la sua preparazione e composizioni farmaceutiche che la contengono.
NZ222051A (en) * 1986-10-06 1990-07-26 Univ Virginia Solution containing adenosine or hypoxanthine and optionally ribose for heart protection during surgery
JPH01501478A (ja) * 1986-11-25 1989-05-25 インスティテュト　オルガニチェスコゴ　シンテザ　アカデミイ　ナウク　ラトビイスコイ　エスエスアール ９―置換グアニン
US4978655A (en) * 1986-12-17 1990-12-18 Yale University Use of 3'-deoxythymidin-2'-ene (3'deoxy-2',3'-didehydrothymidine) in treating patients infected with retroviruses
US4829055A (en) * 1987-01-23 1989-05-09 Naficy Sadeque S Method of treatment for herpes infections of external tissues
US5565566A (en) * 1987-04-24 1996-10-15 Discovery Therapeutics, Inc. N6 -substituted 9-methyladenines: a new class of adenosine receptor antagonists
US4835104A (en) * 1987-06-16 1989-05-30 Ajinomoto Co., Inc., Patent & Licensing Department Process for producing and purifying 2',3'-dideoxynucleosides, and process for producing 2',3'-dideoxy-2',3'-didehydronucleosides
US6306647B1 (en) 1987-06-16 2001-10-23 Ajinomoto Co., Inc. Process for producing and purifying 2′,3′-dideoxynucleosides, and process for producing 2′,3′-dideoxy-2′,3′-didehydronucleosides
GB8725939D0 (en) * 1987-11-05 1987-12-09 Wellcome Found Therapeutic compounds
GB8719367D0 (en) * 1987-08-15 1987-09-23 Wellcome Found Therapeutic compounds
CA1302887C (fr) * 1987-11-24 1992-06-09 Yves Langelier Melange d'acyclovir (ou d'un de ses devises) et de bacitracine
JPH01121424U (fr) * 1988-02-10 1989-08-17
GB8815241D0 (en) * 1988-06-27 1988-08-03 Wellcome Found Antiviral combinations & compounds therefor
US5164395A (en) * 1988-06-27 1992-11-17 Burroughs Wellcome Co. Antiviral acetyl pyridine derivative or said acetyl pyridine derivative in combination with acyclovir
GB8816760D0 (en) * 1988-07-14 1988-08-17 Wellcome Found Therapeutic compounds
JPH02164881A (ja) * 1988-10-24 1990-06-25 Wellcome Found Ltd:The 治療用ヌクレオシド化合物
AU626983B2 (en) * 1989-01-31 1992-08-13 Whitby Research, Inc. N6-substituted 9-methyladenines
US4966895A (en) * 1989-02-02 1990-10-30 Merck & Co. Inc. Cyclic monophosphates of purine and pyrimidine acyclonucleosides as anti-retroviral agents
GB8907173D0 (en) * 1989-03-30 1989-05-10 Beecham Group Plc Novel compounds
GB8912043D0 (en) * 1989-05-25 1989-07-12 Beecham Group Plc Novel compounds
GB9001886D0 (en) * 1990-01-26 1990-03-28 Beecham Group Plc Pharmaceutical formulation
DE4008858A1 (de) * 1990-03-20 1991-09-26 Hoechst Ag Substituierte purine, verfahren zu ihrer hertellung sowie ihre verwendung als antivirale mittel
CA2033447C (fr) * 1990-12-31 1999-08-31 Robert Deziel Complexe synergique pour le traitement des infections herpetiques
US5879700A (en) * 1991-10-15 1999-03-09 Hostetler; Karl Y. Nucleoside analogue phosphates for topical use
US5580571A (en) * 1991-10-15 1996-12-03 Hostetler; Karl Y. Nucleoside analogues
CA2091732C (fr) * 1992-07-08 1998-07-21 Anica Markovac Procede pour la preparation de 2-fluoro-9-(2,3,5-tri-o-benzyl-beta-d-arabinofuranosyl)adenine
DK169121B1 (da) 1992-09-09 1994-08-22 Gea Farmaceutisk Fabrik As Antiviralt virksom farmaceutisk olie-i-vand-emulsion indeholdende 9-[(2-hydroxyethoxy)methyl]guanin (acyclovir) eller et salt eller en ester deraf
DE59310344D1 (de) * 1992-09-24 2003-07-24 Hoechst Ag N1-Substituierte 1H-1,2,3-Triazolo[4,5-d]pyrimidine, Verfahren zu ihrer Herstellung sowie ihre Verwendung als antivirale Mittel
US6015573A (en) * 1993-05-12 2000-01-18 Hostetler; Karl Y. Nucleoside phosphate therapy for viral infection
US5654286A (en) * 1993-05-12 1997-08-05 Hostetler; Karl Y. Nucleotides for topical treatment of psoriasis, and methods for using same
IT1264599B1 (it) * 1993-06-14 1996-10-04 Solar Chem Sa Processo per la sintesi della 9-(2-idrossietossimetil)- guanina
US5567816A (en) * 1994-07-26 1996-10-22 Syntex (U.S.A.) Inc. Preparation of acyclovir using 1,3 dioxolane
US5543414A (en) * 1994-07-28 1996-08-06 Syntex (Usa) Inc. Achiral amino acid acyl esters of ganciclovir and its derivatives
US5856481A (en) * 1994-07-28 1999-01-05 Syntex (U.S.A.) Inc. 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5565565A (en) 1994-08-04 1996-10-15 Syntex (U.S.A.) Inc. Preparation of N-9 substituted guanine compounds
US5627185A (en) * 1994-11-23 1997-05-06 Gosselin; Gilles Acyclovir derivatives as antiviral agents
US5756736A (en) * 1996-01-26 1998-05-26 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US5840890A (en) * 1996-01-26 1998-11-24 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl)methoxy-1,3-propanediol derivative
US6040446A (en) 1996-01-26 2000-03-21 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol derivative
US5700936A (en) * 1996-01-26 1997-12-23 Syntex (U.S.A.) Inc. Process for preparing a 2-(2-amino-1,6-dihydro-6-oxo-purin-9-yl) methoxy-1,3-propanediol valinate
IN179493B (fr) * 1996-02-22 1997-10-11 Lupin Laboraties Ltd
US5789589A (en) * 1996-04-22 1998-08-04 Drug Innovation & Design, Inc. Guanine analog phosphates
US6440980B1 (en) * 1996-09-17 2002-08-27 Avanir Pharmaceuticals Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
US6180790B1 (en) 1997-05-15 2001-01-30 Drug Innovation And Design, Inc. Methods of preparing acyclovir prodrugs
EP0981532B1 (fr) * 1997-05-15 2002-08-28 Drug Innovation & Design, Inc. Derives diesters d'acyclovir
HUP0402624A3 (en) * 2001-10-16 2008-04-28 Avanir Pharmaceuticals Viral inhibition by n-docosanol
US20070129334A1 (en) * 2001-10-30 2007-06-07 Conforma Therapeutics Corporation Orally Active Purine-Based Inhibitors of Heat Shock Protein 90
EP1440072A4 (fr) * 2001-10-30 2005-02-02 Conforma Therapeutic Corp Analogues de purine presentant une activite inhibitrice de hsp90
US7078524B2 (en) 2002-11-22 2006-07-18 Ranbaxy Laboratories Limited Process for the synthesis of ganciclovir
NZ540728A (en) 2003-01-14 2008-08-29 Gilead Sciences Inc Compositions and methods for combination antiviral therapy
US20040200730A1 (en) * 2003-04-14 2004-10-14 Kyo Jibiki Hydrometallurgical copper recovery process
US20080132527A1 (en) 2004-05-19 2008-06-05 Emisphere Technologies, Inc. Compositions For Delivering Acyclovir
TWI375560B (en) 2005-06-13 2012-11-01 Gilead Sciences Inc Composition comprising dry granulated emtricitabine and tenofovir df and method for making the same
TWI471145B (zh) 2005-06-13 2015-02-01 Bristol Myers Squibb & Gilead Sciences Llc 單一式藥學劑量型
CA2644297A1 (fr) * 2006-03-14 2007-09-20 Alt Solutions, Inc. Prevention et traitement des cancers et d'autres maladies
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
CN102325783A (zh) 2008-12-23 2012-01-18 法莫赛特股份有限公司 嘌呤核苷的合成
CA2748034A1 (fr) 2008-12-23 2010-07-01 Pharmasset, Inc. Promedicaments de 2'-deoxy'2'-fluoro-2'-c-methyl-nucleoside-phosphoramidate purifie destines au traitement d'infections virales
SG184323A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasett Llc Stereoselective synthesis of phosphorus containing actives
GB201819418D0 (en) 2018-11-29 2019-01-16 Daniel Calladine Ltd Anti-viral compositions
WO2021209563A1 (fr) 2020-04-16 2021-10-21 Som Innovation Biotech, S.A. Composés destinés à être utilisés dans le traitement d'infections virales par un coronavirus associé au syndrome respiratoire

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4199574A (en) * 1974-09-02 1980-04-22 Burroughs Wellcome Co. Methods and compositions for treating viral infections and guanine acyclic nucleosides
US4146715A (en) * 1975-08-27 1979-03-27 Burroughs Wellcome Co. 2-amido-9-(2-acyloxyethoxymethyl)hypoxanthines

Also Published As

Publication number Publication date
IL48035A0 (en) 1975-11-25
US4294831A (en) 1981-10-13
SE428562B (sv) 1983-07-11
HK84379A (en) 1979-12-14
ES440631A1 (es) 1977-06-16
NO144216C (no) 1981-07-15
BG26389A3 (fr) 1979-03-15
DD122092A5 (fr) 1976-09-12
CH628897A5 (de) 1982-03-31
ES455979A1 (es) 1978-01-16
SU686618A3 (ru) 1979-09-15
BE833006A (fr) 1976-03-02
FR2282892A1 (fr) 1976-03-26
LU73304A1 (fr) 1976-08-13
FI752465A (fr) 1976-03-03
IE42282B1 (en) 1980-07-16
NL175061C (nl) 1984-09-17
DK146595C (da) 1984-04-24
GB1523865A (en) 1978-09-06
RO74275A (fr) 1981-09-24
SE428562C (sv) 1985-08-20
YU40080B (en) 1985-06-30
SU700064A3 (ru) 1979-11-25
YU120182A (en) 1982-08-31
DE2539963A1 (de) 1976-03-18
RO76939A (fr) 1981-06-22
CA1062257A (fr) 1979-09-11
MY8200191A (en) 1982-12-31
CH626364A5 (fr) 1981-11-13
CH629805A5 (de) 1982-05-14
YU120082A (en) 1982-08-31
JPS6147839B2 (fr) 1986-10-21
DE2539963C2 (fr) 1987-01-22
IL48035A (en) 1981-07-31
AR212914A1 (es) 1978-11-15
ZM12875A1 (en) 1977-09-21
SU784777A3 (ru) 1980-11-30
SU904523A3 (ru) 1982-02-07
US4360522A (en) 1982-11-23
HU176730B (en) 1981-04-28
ES455978A1 (es) 1978-01-16
AU8445975A (en) 1977-03-10
YU222075A (en) 1982-08-31
SE7509675L (sv) 1976-03-03
SU858569A3 (ru) 1981-08-23
AR220885A1 (es) 1980-12-15
IE42282L (en) 1976-03-02
ATA676375A (de) 1979-06-15
SU751325A3 (ru) 1980-07-23
BG25094A3 (en) 1978-07-12
CH623587A5 (fr) 1981-06-15
NL175061B (nl) 1984-04-16
NZ178556A (en) 1978-09-25
DK392675A (da) 1976-03-03
RO74276A (fr) 1981-06-26
RO74274A (fr) 1981-09-24
US4323573A (en) 1982-04-06
NO144216B (no) 1981-04-06
YU119982A (en) 1982-08-31
SU799664A3 (ru) 1981-01-23
KE3002A (en) 1979-12-14
ZA755574B (en) 1977-04-27
CY1033A (en) 1980-08-01
YU40079B (en) 1985-06-30
NO753009L (fr) 1976-03-03
CH623586A5 (fr) 1981-06-15
FI60709B (fi) 1981-11-30
CS203092B2 (en) 1981-02-27
AU503160B2 (en) 1979-08-23
NL7510342A (nl) 1976-03-04
JPS5154589A (en) 1976-05-13
AR220299A1 (es) 1980-10-31
FR2282892B1 (fr) 1980-04-25
FI60709C (fi) 1982-03-10
AR220508A1 (es) 1980-11-14
MC1068A1 (fr) 1976-05-21
CH626363A5 (fr) 1981-11-13
YU39947B (en) 1985-06-30
CS203093B2 (en) 1981-02-27
BG24815A3 (en) 1978-05-12
CH629206A5 (de) 1982-04-15
DK146595B (da) 1983-11-14
AT354462B (de) 1979-01-10

Similar Documents

Publication Publication Date Title
FR2282892B1 (fr)
JPS5140809A (fr)
JPS50132419A (fr)
JPS5112580A (fr)
JPS50135553A (fr)
JPS50145461A (fr)
JPS5133096A (fr)
JPS5247133B2 (fr)
JPS5149705U (fr)
JPS50146581U (fr)
JPS5151277U (fr)
JPS5127155U (fr)
JPS5098315U (fr)
JPS5135688A (fr)
JPS5137909U (fr)
JPS50159388A (fr)
BG21054A1 (fr)
CH580821A5 (fr)
BG19923A1 (fr)
BG19878A1 (fr)
BG20674A1 (fr)
BG20681A1 (fr)
CH581858B5 (fr)
BG21081A1 (fr)
BE834963A (fr)